发明授权
US06733782B1 Core tablet for controlled release of gliclazide after oral administration
有权
用于口服给药后格列齐特治疗的核心片剂
- 专利标题： Core tablet for controlled release of gliclazide after oral administration
- 专利标题（中）： 用于口服给药后格列齐特治疗的核心片剂
-
申请号： US09890427申请日： 2001-07-31
-
公开(公告)号： US06733782B1公开(公告)日： 2004-05-11
- 发明人: Bruno Huet De Barochez , Patrick Wuthrich , Louis Martin
- 申请人： Bruno Huet De Barochez , Patrick Wuthrich , Louis Martin
- 优先权： FR9901082 19990201
- 主分类号： A61K920
- IPC分类号： A61K920
摘要：
The invention relates to a matrix tablet for the prolonged release of gliclazide which ensures continuous and consistent release of the active ingredient after administration by the oral route, the release being insensitive to variations in the pH of the dissolution medium.
信息查询
